Reported Adverse Events from the use of Homeopropylaxis in FHCi HPx Programs

Definition: An adverse event is defined as a death, life-threatening adverse drug or device experience, inpatient hospitalization or prolongation of existing hospitalization, a persistent disability/incapacity, or a congenital anomaly/birth defect.

Free and Healthy Children International (FHCi) has been supplying access to Homeoprophylaxis (HP) since 2009. From  January 2009 to December of 2014 all families participating in HP as offered by FHCi were entered in the program under research. To date no children in the study have reported an adverse event.

Since January of 2009 approximately 2000 more children have participated in the HP program as offered by FHCi. To date no adverse events have been reported.

To report an adverse event please follow the directions here.

Once a case has been reviewed by the Adverse Event Reporting Committee results will be published here.

FHCi has been tracking remedy responses since 2013.

  • Adverse Events under review: (0) Dec 1,2022.
  • Reported Adverse Events: (0) Dec 1, 2022.
  • Adverse Events during the ten-year childhood HP program research registrants (682) (0) events reported.
  • Total children to register with FHCi since 2009 -May 25, 2021: 2116: (0) events reported.
  • Total participants in FHCi 2020 Coronavirus research 1169: (0) events reported.
  • Total families (a family is one or more participants up to 8) registered in Coronavirus prevention as of Dec  1, 2022: 1350, (0) events reported.